EMBARK study

Phase 3b Open-Label, Multicenter, Safety Study of BIIB037 (aducanumab) in Subjects with Alzheimer’s disease Who Had Previously Participated in the Aducanumab Studies 221AD103, 221AD301, 221AD302 and 221AD205. Data EDC pdf files End Of study / IRT site audit file / WCG data

Organizational unit

Centre de la Mémoire - HUG

Type

Dataset

DOI

10.26037/yareta:ehzhc3owzrex5ozst6m4345qxa